All treatments that extend the tumor-free period in mice bearing Eμ-Myc/eIF-4E lymphomas had no effect on overall survival in mice bearing Eμ-Myc/Bcl-2 tumors (Fig. S3B). Here, BCL2 is linked to lymphoma.